HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT)
Clinical trials for HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) trials appear
Sign up with your email to follow new studies for HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to ease heart strain in rare blood vessel disorder
Disease control ENROLLING_BY_INVITATIONThis study is testing whether a drug called bevacizumab can help people with hereditary hemorrhagic telangiectasia (HHT) who have severe liver problems that are putting extra strain on their heart. It will involve 111 patients in France who are already receiving this drug through…
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT)
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Tracking Long-Term results of promising bleeding disorder treatment
Disease control OngoingThis study follows patients with hereditary hemorrhagic telangiectasia (HHT) who previously participated in a trial testing pomalidomide for bleeding control. Researchers are tracking these patients over time to understand the long-term safety and effectiveness of the treatment. …
Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT)
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC